ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.
about
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppressionANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modificationTumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypesEstrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAsRegulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenE2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferasesMir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNASteroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiationNeuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1Noncoding RNA in oncogenesis: a new era of identifying key playersNuclear receptor coregulators: modulators of pathology and therapeutic targetsTo live or let die - complexity within the E2F1 pathwayIdentification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen ReceptorSRC-3 has a role in cancer other than as a nuclear receptor coactivator.Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.Antiestrogens: structure-activity relationships and use in breast cancer treatmentNuclear receptor coactivators: the key to unlock chromatinIdentification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitorThe active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cellsPrior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast CancerThe cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survivalRegulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expressionDeregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy PhenotypeRegulation of hormonal therapy resistance by cell cycle machinery.Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancerSteroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02.E2F activators signal and maintain centrosome amplification in breast cancer cells.Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology.Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cellsNormal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
P2860
Q24299196-55DFAC92-9A52-40E6-8617-90229E968070Q24300315-7B932EAB-EB8D-42FC-9D73-E09CDB36D54DQ24303428-C41F01A1-42B9-48A0-A75C-30C4E00D56EAQ24617123-6D350EDB-61D7-4D5B-AEB6-B6384F1281ABQ24631037-43B0B09A-25DC-41BB-A272-49F381B07AF5Q24632895-6FE53874-5A71-4CBE-B186-E8F14CB426B6Q24646412-F7FDB6DD-08EB-4A2C-8A38-A0D29EED6302Q24672429-F94AFC39-C1AE-4DF8-A011-8D57689C7548Q24681162-361923B1-AB88-41CD-9753-A748C19CAD8CQ24681497-DFFDA55C-F2E9-4945-B7B5-308D720F16FCQ26823718-B705A8AC-23BE-4979-8A4C-2FFF541447FDQ26859163-144A5345-57E0-4EBF-BABF-D4260AF13D80Q26862588-4356915C-CB8C-4261-BF38-0060B74E3FBCQ27659041-8A9AA452-DF35-429F-A4E4-D08CC27A7563Q27687681-E1D6A846-520B-4850-930E-5212F9A1B97AQ27852024-38928D5F-4892-4ED7-AF42-FAE7FFFBB3D3Q28077245-8AF7A59D-A271-4677-A607-EE41107F8FB8Q28266740-806969D7-535D-4B5F-8565-502789589859Q28538014-9ECFC001-7A9B-4025-B28F-57BCCFF62166Q28546094-43ABD47C-CFB1-470D-B239-B3DBDDFF2D81Q28550645-86CACBCD-0AC2-4D99-A889-D908647A2A54Q28591566-41FCEB51-DC9C-4C59-9BA4-1707620EC747Q30480773-D122C2DC-7A94-4F4B-B629-E407B420FAFEQ30493310-D7B27DC5-AB4A-4645-88BB-9A45625A58F6Q30610162-F185C55A-21D8-4DA1-86FE-DF9663A9D259Q30659017-75FA7DD4-D166-4C90-B609-FCBF3EE7AF76Q33635621-4A0AEBA6-D78F-4080-AB0F-CD656C91A977Q33676302-37898507-2A1E-4FFD-9E49-6601288924B7Q33715865-F1312D52-004E-425F-A7C9-F9AB6F74DC10Q33748262-C9E5F30E-51A5-45E3-837A-B2FB5147199BQ33780204-E5DB0441-66DA-4BB6-815D-6D816FF7FC00Q33853065-549D3FF5-D690-4DB6-A467-5BC1D722D63DQ33872793-960816BD-2D32-449F-97DE-909343DF6FD3Q33874323-3E7BEB12-C9C9-4796-813B-24C65297CB42Q33879017-75C31C4D-F7EA-4607-8CA8-9976FF852DFAQ33899840-6F4366FF-6DE5-4E20-977C-E7AFA842A9FBQ33934565-8D20ED41-1224-42A3-B0AB-2334319E0E9FQ33967943-F48E2ADB-8AAC-481A-A34B-6FD3AC72DC09Q34006827-4B6D20EF-5A47-48CF-9676-8979ED691889Q34013708-1077C925-F17C-4F49-ABE7-44B18C2754B4
P2860
ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@ast
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@en
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@nl
type
label
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@ast
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@en
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@nl
prefLabel
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@ast
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@en
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@nl
P2093
P2860
P1476
ACTR/AIB1 functions as an E2F1 ...... n and antiestrogen resistance.
@en
P2093
Alina Rabinovich
Hong-Wu Chen
June X Zou
Maggie C Louie
P2860
P304
P356
10.1128/MCB.24.12.5157-5171.2004
P407
P577
2004-06-01T00:00:00Z